Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Tarsus Pharmaceuticals
AddedFeb 19, 2024
UpdatedJun 18, 2026
Tarsus Pharmaceuticals

Tarsus Pharmaceuticals

Public

Tarsus: A private, clinical-stage biopharmaceutical firm based in Irvine, California.

HQ
Irvine, CA, US
Founded
2017
Overview
Compare
Fundraising
Employees
Website

Tarsus Pharmaceuticals, founded in Irvine, California, is a privately held, clinical-stage biopharmaceutical company. The company's core mission is to revolutionize treatment for patients with limited therapeutic options by delivering innovative therapies. Tarsus focuses on developing novel therapeutics, starting with treatments for eye diseases. Their flagship product addresses Demodex blepharitis, providing an FDA-approved solution for millions of patients suffering from this condition.

Notable figures affiliated with Tarsus include a team of experienced biopharmaceutical professionals dedicated to advancing medical treatments. The company has achieved significant milestones, including the development and FDA approval of their treatment for Demodex blepharitis. Tarsus's impact lies in its commitment to addressing unmet medical needs, thereby improving patient outcomes and setting new standards in therapeutic ingenuity.

Tarsus Pharmaceuticals - Similar Companies

Telsar Pharma logo

Telsar Pharma

Tigris Pharmaceuticals logo

Tigris Pharmaceuticals

tigrispharma.com

Surface Pharmaceuticals logo

Surface Pharmaceuticals

surfacepharma.com

Arcutis Biotherapeutics logo

Arcutis Biotherapeutics

arcutis.com

Thar Pharmaceuticals logo

Thar Pharmaceuticals

tharpharma.com

Thesan Pharmaceuticals logo

Thesan Pharmaceuticals

thesanpharma.com

Theracos logo

Theracos

theracos.com

ARS Pharmaceuticals logo

ARS Pharmaceuticals

ars-pharma.com

Visiox logo

Visiox

visioxpharma.com

Tisbury Pharmaceuticals logo

Tisbury Pharmaceuticals

Terns Pharmaceuticals logo

Terns Pharmaceuticals

ternspharma.com

Corbus Pharmaceuticals Holdings logo

Corbus Pharmaceuticals Holdings

corbuspharma.com

TearClear logo

TearClear

tearclear.com

TBT Pharma logo

TBT Pharma

tbtpharma.com

Iacta Pharmaceuticals logo

Iacta Pharmaceuticals

Tarsus Pharmaceuticals - Quick Facts

Who are Tarsus Pharmaceuticals' competitors?

Companies similar to Tarsus Pharmaceuticals include Telsar Pharma, Tigris Pharmaceuticals, Surface Pharmaceuticals and Arcutis Biotherapeutics.

When was Tarsus Pharmaceuticals founded?

Tarsus Pharmaceuticals was founded in 2017.

Where is Tarsus Pharmaceuticals' headquarters located?

Tarsus Pharmaceuticals' headquarters is located in Irvine, CA, US.

When was Tarsus Pharmaceuticals' last funding round?

Tarsus Pharmaceuticals' most recent funding round was for $100M (USD) in August 2023.

How much has Tarsus Pharmaceuticals raised to-date?

As of Aug 1, 2023, Tarsus Pharmaceuticals has raised a total of $410.6M (USD).

How many employees does Tarsus Pharmaceuticals have?

Tarsus Pharmaceuticals has 251 employees as of Feb 6, 2024.

Tarsus Pharmaceuticals - Classification

Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Therapeutics
Tags
  • Biotech
Unique IDs
  • ein: 814717861
  • secCik: 0001819790
  • ticker: TARS
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2836Biological Products, Except Diagnostic Substances
  • 2800Chemicals And Allied Products
  • 2830Drugs
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 16 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325414Biological Product (except Diagnostic) Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research